Go Pro
NASDAQ:XRTX

XORTX Therapeutics Q1 2026 Earnings Report

XORTX Therapeutics logo
$2.13 0.00 (0.00%)
Closing price 08/7/2026 03:57 PM Eastern
Extended Trading
$2.13 0.00 (0.00%)
As of 08/7/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

XORTX Therapeutics EPS Results

Actual EPS
-$0.58
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

XORTX Therapeutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

XORTX Therapeutics Announcement Details

Quarter
Q1 2026
Time
After Market Closes
Conference Call Date
Friday, May 15, 2026
Conference Call Time
4:00PM ET

Upcoming Earnings

XORTX Therapeutics' Q2 2026 earnings is estimated for Thursday, August 13, 2026, based on past reporting schedules

Conference Call Resources

XORTX Therapeutics Earnings Headlines

XORTX Therapeutics Inc.: XORTX Announces Director Resignation
China is not hedging. It's escaping.
China's US Treasury holdings have fallen from a peak of $1.32 trillion to roughly $659 billion, an 18-year low. Beijing's central bank has bought gold for 20 straight months, its longest streak in a decade. Goldman Sachs estimates China's real gold buying is 4.8 times the official figure. The European Central Bank confirms gold has overtaken US Treasuries as the world's top reserve asset, at 27% versus 22%. As foreign demand for US debt fades, rates and everyday costs may feel the pressure.tc pixel
XORTX Announces Director Resignation
XORTX Announces Director Resignation
See More XORTX Therapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like XORTX Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on XORTX Therapeutics and other key companies, straight to your email.

About XORTX Therapeutics

Xyratex Ltd (Xyratex) is a provider of data storage technology, including modular solutions for the enterprise data storage industry and hard disk drive (HDD) capital equipment for the HDD industry. Xyratex operates in two segments: Networked Storage Solutions (NSS) and Storage Infrastructure (SI). Its NSS products are primarily HDD based data storage subsystems and solutions, which it provides to original equipment manufacturers. Its SI products consist of HDD manufacturing process equipment, which it sells directly to manufacturers of HDDs and their component suppliers. Its product and solution portfolio for the enterprise data storage industry includes storage enclosures, integrated application platforms and high performance computing (HPC) data storage solutions. In April 2014, Seagate Technology PLC completed the acquisition of Xyratex Ltd.

View XORTX Therapeutics Profile